???global.info.a_carregar???
Carina Peres is currently a Post-Doctoral research fellow at Prof. Adriana Santos' lab (3DS - Drug Discovery, Development and Safety group) at the Health Sciences Research Centre (CICS), integrated in the University of Beira Interior. Carina has a BSc and a MSc degrees in Biochemistry awarded by the Universidade da Beira Interior. She concluded her PhD degree in 2020 in Pharmacy (specialty: Pharmaceutical technology) awarded by the Faculty Pharmacy of the University of Lisbon. Carina started her research carrier in 2009, when she was awarded with an Integration into Research Grant in cancer biology field, at the Health Sciences Research Centre (CICS), integrated in the Faculty of Sciences - Universidade da Beira Interior. Carina participated in other research projects in cancer field during her Master Thesis in Biochemistry at the Universidade da Beira Interior, and then, at the University of York, during a summer research internship funded by the prestigious International Association for the Exchange of Students for Technical Experience (IASTE) scheme. Later, Carina developed her PhD studies at Prof. Helena Florindo's lab (iMed.ULisboa) in the development and assessment of a breast carcinoma vaccine based on a multifunctional engineered-nanoparticulate system able to target dendritic cells (DC), as well as to modulate immunosuppressive cytokine levels at tumor microenvironment. In 2020, she started a Post-Doctoral position of a LaCaixa-funded international consortium (CoVax, LCF/TR/CD20/52700005) on COVID nanomedicine field, involving iMedULisboa (Lisboa, Portugal), and Tel Aviv University (Tel Aviv, Israel). Carina is also participating in other 3 international research consortia, namely i) LaCaixa-funded international consortium NanoPanther (LCF/PR/HR19/52160021) on pancreatic cancer nanomedicine field involving iMed.ULisboa (Lisboa, Portugal), Prince Felipe Research Center (CIPF) (Valencia, Spain) and Tel Aviv University (Tel Aviv, Israel), ii) FCT-funded project NanoMetBrain (PTDC/BTM-SAL/4350/2021), on melanoma-brain metastasis nanomedicine field involving iMed.ULisboa (Lisboa, Portugal), IMM (Lisboa, Portugal) and Tel Aviv University (Tel Aviv, Israel), and iii) FCT-funded project NxGNanoTher (UTAP-EXPL/NPN/0041/2021), on breast cancer nanomedicine field involving iMed.ULisboa (Lisboa, Portugal), IMM (Lisboa, Portugal) and University of Texas (Austin, USA), in which she has a core function. Overall, Carina interacted with more than 50 authors (+10 nationalities), publishing in total 13 articles, 4 book chapters, and 5 conference proceedings with a cumulative impact factor of 134 and a total of 446 citations. The publication list includes top specialty journals, as Nat Nanotech, Adv Drug Deliv Rev, J Control Release or Acta Biomater. Carina also presented her work at several national and international meetings (8 oral communications and 18 posters). She was supported with 4 travel grants from renowned scientific societies to participate in highly recognized international meetings, including the Federation of European Biochemical Societies (FEBS) and the Association for Cancer Immunotherapy (CIMT). Also, Carina was awarded 2 travel grants by the European Commission sponsored COST Mission (BM1402) to enroll in a training school at MRC Harwell (UK) and another at Novartis (Basel, Switzerland). She had also been part of the team of 5 FCT-funded projects, and 2 international consortiums. Carina is also involved in the lab management and is actively mentoring and/or supervising PhD and MSc students, and undergraduate students (research training within Project curricular unit at FFUL). Also, she has been involved in the organization of 5 national and 1 international scientific meetings.
Read full resume ↓
Identification

Personal identification

Full name
Carina Sofia Gonçalves Peres

Citation names

  • Peres, Carina

Author identifiers

Ciência ID
1211-6FBA-E335
ORCID iD
0000-0001-9399-9156
Google Scholar ID
https://scholar.google.pt/citations?user=KxsBcdIAAAAJ&hl=pt-PT&oi=ao
Scopus Author Id
56797773600

Email addresses

  • cperes@fcsaude.ubi.pt (Professional)
  • carinaperes.bq@gmail.com (Personal)

Addresses

  • CICS-UBI - Health Sciences Research Centre, Faculty of Health Sciences, University of Beira Interior, 6200-506, Covilhã, Covilhã, Portugal (Professional)

Websites

Knowledge fields

  • Engineering and Technology - Nano-technology
  • Medical and Health Sciences - Basic Medicine - Pharmacology and pharmacy
  • Medical and Health Sciences - Basic Medicine - Immunology
  • Medical and Health Sciences - Health Sciences
  • Medical and Health Sciences - Health Sciences - Infectious Diseases

Languages

Language Speaking Reading Writing Listening Peer-review
English Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
French Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2)
German Beginner (A1) Elementary (A2) Beginner (A1) Beginner (A1) Beginner (A1)
Portuguese (Mother tongue)
Education
Degree Classification
2023/06/19 - 2023/07/30
Ongoing
 Clinical Trials (Pós-Graduação)
Universidade de Lisboa Faculdade de Medicina, Portugal
2020/05
Concluded
 Pharmacy (Doutoramento)
Major in Pharmaceutical technology
Universidade de Lisboa Faculdade de Farmácia, Portugal
"Intracellularly-targeted nanoplatform to target dendritic cells and for immunomodulation" (THESIS/DISSERTATION)
 Summa cum laude
2014/10 - 2014/10
Concluded
 Course on Laboratory Animal Science (FELASA Category B) (Diploma de especialização)
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
2014/03 - 2014/03
Concluded
 Advanced Training Course on Cell Culture (Diploma de especialização)
Universidade Lusófona, Portugal
 18
2012/06
Concluded
 Biochemistry (Mestrado integrado)
Universidade da Beira Interior, Portugal
"Androgens in breast cancer cells physiology: a connection with calcium homeostasis?" (THESIS/DISSERTATION)
 18
2010/06
Concluded
 Biochemistry (Licenciatura)
Universidade da Beira Interior, Portugal
 16
Affiliation

Science

Category
Host institution 		Employer
2022/07/01 - 2023/06/30 Postdoc (Research) Universidade da Beira Interior Centro de Investigação em Ciências da Saúde, Portugal
2020/12 - 2022/06/30 Postdoc (Research) Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
2015/03 - 2022/06/30 Visiting Researcher (Research) Instituto de Medicina Molecular João Lobo Antunes, Portugal
Instituto de Medicina Molecular João Lobo Antunes, Portugal
2013/03 - 2022/06/30 Researcher (Research) Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
2012/08 - 2012/09 Researcher (Research) University of York Centre for Immunology and Infection, United Kingdom
University of York Centre for Immunology and Infection, United Kingdom
2011/09 - 2012/06 Research Trainee (Research) Universidade da Beira Interior Centro de Investigação em Ciências da Saúde, Portugal
Universidade da Beira Interior Centro de Investigação em Ciências da Saúde, Portugal
2009/09 - 2010/08 Research Trainee (Research) Universidade da Beira Interior Centro de Investigação em Ciências da Saúde, Portugal
Universidade da Beira Interior Centro de Investigação em Ciências da Saúde, Portugal

Others

Category
Host institution 		Employer
2013/03 - 2022/06/30 Laboratory Management Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
Projects

Grant

Designation Funders
2022/07/01 - 2023/06/30 SAIN - Segesterone Acetate Intranasal Nanoemulsion
CENTRO-45-2021-02
Post-doc
Universidade da Beira Interior Centro de Investigação em Ciências da Saúde, Portugal
Ongoing

Contract

Designation Funders
2022/01/01 - Current Multifunctional nano-immunotherapy for melanoma brain metastases treatment
PTDC/BTM-SAL/4350/2021
Post-doc
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Instituto de Medicina Molecular João Lobo Antunes, Portugal

Tel Aviv University Sackler Faculty of Medicine, Israel
Fundação para a Ciência e a Tecnologia
Ongoing
2022/01 - 2023/07/30 Next-generation nanomaterials to sensitize breast cancer to immunotherapy
UTAP-EXPL/NPN/0041/2021
Post-doc
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Instituto de Medicina Molecular João Lobo Antunes, Portugal

The University of Texas at Austin, United States
Ongoing
2021/01 - 2022/06/30 Sensitizing pancreatic cancer to immunotherapy with multimodal precision nanomedicines
LCF/PR/HR19/52160021
Post-doc
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Fundación de la Comunidad Valenciana Centro de Investigación Príncipe Felipe, Spain

Tel Aviv University Sackler Faculty of Medicine, Israel
“La Caixa” Banking Foundation
Ongoing
2020/12 - 2022/06/30 Development of a translational COVID-19 Vaccine
_
Post-doc Fellow
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Tel Aviv University Sackler Faculty of Medicine, Israel
“La Caixa” Banking Foundation
Cancelled
2019/09 - 2020/09 Modulation of melanoma-stroma interactions using a rationally designed nanomedicine combining BRAFi, MEKi and immunotherapies
ENMed/0051/2016
Research Fellow
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Tel Aviv University Sackler Faculty of Medicine, Israel

Weizmann Institute of Science, Israel
Fundação para a Ciência e a Tecnologia
2018/07 - 2019/06 Targeting tumor microenvironment by a translational multivalent nanomedicine: towards an effective anticancer combination immunotherapy
ENMed/0003/2015
Research Fellow
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
 Fundação para a Ciência e a Tecnologia
2017/06 - 2018/05 Multidisciplinary Strategy to Develop Novel Multicomponent Nanoscale Systems for Immune Modulation
UTAP-ICDT/DTP-FTO/0016/2014
Research Fellow
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
 Fundação para a Ciência e a Tecnologia
2014/04 - 2015/09 TherMelVac - Dendritic cell-targeted peptide vaccine against melanoma by ligand-modified nanoparticles
PTDC/SAU-FAR/119389/2010
Researcher
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
 Fundação para a Ciência e a Tecnologia
Outputs

Publications

Book chapter
  1. Silva, A.L.; Moura, L.I.F.; Carreira, B.; Conniot, J.; Matos, A.I.; Peres, C.; Sainz, V.; et al. "Functional Moieties for Intracellular Traffic of Nanomaterials". 399-448. 2018.
  2. Lambricht, L.; Peres, C.; Florindo, H.; Préat, V.; Vandermeulen, G.. "Polymer-Based Nanoparticles as Modern Vaccine Delivery Systems". 185-203. 2017.
  3. Gaspar, Diana; Peres, Carina; Helena F Florindo; Almeida, António. "Mucosal Immunization Using Polyester-Based Particulate Systems". In Handbook of Polyester Drug Delivery Systems, 521-561. Singapore: Pan Stanford, 2016.
    10.1201/b20045-17
  4. Zupancic, Eva; Silva, Joana; Peres, Carina; Silva, Liana C; Gaspar, Rogerio S; Préat, Véronique; Helena F Florindo. "Immunomodulation against microbial pathogens through dendritic cells". In Microbial pathogens and strategies for combating them: science, technology and education, 1686-1705. Formatex Research Center, 2013.
    Published
Conference paper
  1. Ana I. Matos; Peres, Carina; Moura, Liane I F; Carreira, Bárbara; Viana, Ana S. or Viana, Ana; Graca, Luis; Gaspar, Rogerio S; Conde, J.P.; Helena F Florindo. "PO-415 Multivalent polymeric nanoparticles as an innovative cancer immunotherapy for colorectal cancer". 2018.
    10.1136/esmoopen-2018-eacr25.926
  2. Moura, Liane I F; Duro-Castano, A; Peres, Carina; Gallon, E; Ana I. Matos; Vicent, MJ; Helena F Florindo. "PO-416 A novel multifunctional polypeptide-based platform as an immunotherapeutic approach for melanoma". 2018.
    10.1136/esmoopen-2018-EACR25.927
  3. Peres, Carina; Ana I. Matos; Viana, Ana S. or Viana, Ana; Graca, Luis; Préat, Véronique; Helena F Florindo. "ML-07.01.3-001: Nanoparticle-based cancer vaccine to target dendritic cells and the tumor microenvironment". 2016.
    10.1111/febs.13805
  4. Ricardo J Marques; Vaz, CV; Peres, Carina; Gomes, I.; SANTOS, Cecilia R A; Maia, Cláudio J. B.; Socorro, Sílvia. "177 Effect of Androgens on the Expression of Ca2+-binding Protein, Regucalcin, and Ca2+-channels in MCF-7 Cells". 2012.
    10.1016/s0959-8049(12)70876-6
  5. Maia, Cláudio J. B.; Vaz, CV; Peres, Carina; SANTOS, Cecilia R A; Socorro, Sílvia. "Regucalcin, a calcium-binding protein, is a new target gene in human prostate cancer?". 2010.
Conference poster
  1. Peres, Carina. "Stable Segesterone Acetate Nanoemulsions for Neuroprotection". Paper presented in EUFEPS Annual Meeting 2023, 2023.
  2. Acúrcio, Rita C; Mendes, Nicole; Carreira, Bárbara; Ana I. Matos; Peres, Carina; Vicent, Maria; Satchi-Fainaro, Ronit; Helena F Florindo. "Unlocking Pancreatic Cancer to Nano-Immunotherapy". Paper presented in EACR 2022 Congress - Innovative Cancer Science: Translating Biology to Medicine, 2022.
  3. Peres, Carina; Ana I. Matos; Moura, Liane I F; Carreira, Bárbara; Graca, Luis; Satchi-Fainaro, Ronit; Helena F Florindo. "Multifunctional nanovaccine synergizes with OX40 agonist in triple-negative breast cancer". Paper presented in EACR 2022 Congress - Innovative Cancer Science: Translating Biology to Medicine, 2022.
  4. Ana I. Matos; Peres, Carina; Moura, Liane I F; Carreira, Bárbara; Viana, A. S.; Graca, Luis; Satchi-Fainaro, Ronit; Helena F Florindo. "Targeted nanovaccine as a powerful platform to improve immune modulation and checkpoint therapies in colorectal cancer". Paper presented in EACR 2022 Congress - Innovative Cancer Science: Translating Biology to Medicine, 2022.
  5. Moura, Liane I F; Malfanti, Alessio; Duro-Castano, A; Dordevic, S; Matos, Ana I.; Carina G. Peres; Carreira, Bárbara; et al. "Multivalent branched polypeptide-based nanovaccine as a novel immunotherapeutic approach for melanoma". Paper presented in II ASPIC-ASEICA International Meeting – Current Trends of Precision Medicine in Cancer., 2021.
  6. Peres, Carina; Ana I. Matos; Moura, Liane I F; Conniot, João; Carreira, Bárbara; Viana, Ana S. or Viana, Ana; Préat, Véronique; et al. "Multifunctional nanovaccine synergizes with immune checkpoint therapy against triple-negative breast cancer". Paper presented in EACR-AACR-ASPIC Conference: Tumor Microenvironment, 2020.
  7. Conniot, João; Scomparin, Anna; Carreira, Bárbara; Peres, Carina; Ana I. Matos; Acúrcio, Rita C; Moura, Liane I F; et al. "Functionalized nanobiomaterials as novel combination immunotherapies in cancer". Paper presented in EACR-AACR-ASPIC Conference: Tumor Microenvironment, 2020.
  8. Ana I. Matos; Pena, Sandra; Mateus, Mariana; Carreira, Bárbara; Peres, Carina; Moura, Liane I F; Viana, Ana S. or Viana, Ana; et al. "Targeted nanovaccine as a powerful platform to improve immune modulation therapy in colorectal cancer". Paper presented in EACR-AACR-ASPIC Conference: Tumor Microenvironment, 2020.
  9. Peres, Carina; Tanaka, Yuetsu; Martin, Fabiola; Fox, James. "Flow cytometric methodology for the detection of de novo human T-lymphotropic virus-1 infection in vitro and as a tool to study novel infection inhibitors". Paper presented in 19th International Congress HTLV 2019, 2019.
  10. Peres, Carina; Ana I. Matos; Moura, Liane I F; Conniot, João; Carreira, Bárbara; Viana, Ana S. or Viana, Ana; Graca, Luis; et al. "Nanoparticle-based vaccine improved the anti-tumor efficacy of the immune checkpoint co-stimulator OX40 in breast carcinoma". Paper presented in 10th iMed.ULisboa Postgraduate Students Meeting & 3rd i3DU Meeting, 2018.
  11. Peres, Carina; Conniot, João; Moura, Liane I F; Ana I. Matos; Scomparin, Anna; Yeini, Eilam; Graca, Luis; et al. "Polymeric Nano-vaccines Improved OX40 Anti-tumor Efficacy Against Breast Cancer". Paper presented in Controlled Release Society Annual Meeting and Exposition, 2018.
  12. Conniot, João; Scomparin, Anna; Peres, Carina; Yeini, Eilam; Pozzi, Sabina; Zupancic, Eva; Jung, Steffen; Satchi-Fainaro, Ronit; Helena F Florindo. "Dendritic Cell-targeted Nano-vaccines Synergize with Immune Checkpoint Therapy for Melanoma". Paper presented in Frontiers in Immunomodulation and Cancer Therapy, 2018.
  13. Moura, Liane I F; Duro-Castano, A; Peres, Carina; Gallon, Elena; Sainz, Vanessa; Ana I. Matos; Vicent, María J.; Helena F Florindo. "A novel multifunctional polypeptide-based platform as an immunotherapeutic approach for melanoma". Paper presented in Frontiers in Immunomodulation and Cancer Therapy, 2018.
  14. Moura, Liane I F; Duro-Castano, A; Peres, Carina; Gallon, Elena; Sainz, Vanessa; Ana I. Matos; Vicent, María J.; Helena F Florindo. "A novel multifunctional polypeptide-based platform as an immunotherapeutic approach for melanoma.". Paper presented in 25th Biennial Congress of the European Association for Cancer Research, 2018.
  15. Ana I. Matos; Peres, Carina; Moura, Liane I F; Carreira, Bárbara; Viana, Ana S. or Viana, Ana; Graca, Luis; Gaspar, Rogerio S; Conde, J.P.; Helena Florindo. "Multivalent polymeric nanoparticles as an innovative cancer immunotherapy for colorectal cancer". Paper presented in EACR25: From Fundamental Insight to Rational Cancer Treatment, 2018.
  16. Moura, Liane I F; Duro-Castano, A; Peres, Carina; Gallon, Elena; Sainz, Vanessa; Ana I. Matos; Vicent, María J.; Helena F Florindo. "A novel multifunctional polypeptide-based nanosystem as an anti-cancer immunotherapeutic approach for melanoma.". Paper presented in 12th International Symposium on Polymer Therapeutics: From Laboratory to Clinical Practice, 2018.
  17. Conniot, João; Scomparin, Anna; Peres, Carina; Yeini, Eilam; Pozzi, Sabina; Zupancic, Eva; Jung, Steffen; Satchi-Fainaro, Ronit; Helena F Florindo. "Dendritic Cell-targeted Nano-vaccines Synergize with Immune Checkpoint Therapy for Melanoma". Paper presented in 16th CIMT Annual Meeting – Pushing Frontiers in Cancer Immunotherapy., 2018.
  18. Ana I. Matos; Peres, Carina; Moura, Liane I F; Carreira, Bárbara; Viana, Ana S. or Viana, Ana; Graca, Luis; Gaspar, Rogério; Conde, J.P.; Helena F Florindo. "Multivalent polymeric nanoparticles for combinatorial innovative colorectal cancer immunotherapy and immunomodulation". Paper presented in 16th CIMT Annual Meeting – Pushing Frontiers in Cancer Immuntherapy, 2018.
  19. Peres, Carina; Ana I. Matos; Moura, Liane I F; Carreira, Bárbara; Scomparin, Anna; Yeini, Eilam; Viana, Ana S. or Viana, Ana; et al. "Nanoparticle-based vaccine improved OX40 anti-tumor efficacy in breast cancer". Paper presented in 16th CIMT Annual Meeting – Pushing Frontiers in Cancer Immunotherapy., 2018.
  20. Ana I. Matos; Peres, Carina; Moura, Liane I F; Carreira, Bárbara; Viana, Ana S. or Viana, Ana; Graca, Luis; Gaspar, Rogério; Conde, J.P.; Helena Florindo. "Multivalent PLGA-based nanoparticles for combinatorial innovative colorectal cancer immunotherapy and immunomodulation". Paper presented in 3rd ASPIC International Congress, 2018.
  21. Moura, Liane I F; Duro-Castano, A; Peres, Carina; Gallon, Elena; Sainz, Vanessa; Ana I. Matos; Vicent, María J.; Helena Florindo. "Multifunctional polypeptide-based platform as an anti-cancer immunotherapeutic approach for melanoma". Paper presented in XII Spanish-Portuguese Conference on Controlled Drug Delivery, 2018.
  22. Coelho, Ainhoa; Peres, Carina; Conniot, João; Afonso, C.A.; Helena Florindo; Lopes, João. "A Quality-By-Design Approach for the Understanding of the Effect of Model of Antigen Mannose on PLGA Nanoparticles". Paper presented in XXV Encontro Nacional de Química, 2017.
  23. Peres, Carina; Moura, Liane I F; Ana I. Matos; Sainz, Vanessa; Viana, Ana S. or Viana, Ana; Gaspar, Rogério; Graca, Luis; Préat, Véronique; Helena F Florindo. "Polymeric nanoparticles as cancer vaccines and immunomodulators". Paper presented in 9th iMed.ULisboa Postgraduate Students Meeting & 2nd i3DU Meeting, 2017.
  24. Ana I. Matos; Peres, Carina; Moreiras, Hugo; Viana, Ana S. or Viana, Ana; Graca, Luis; Barral, Duarte C.; Conde, J.P.; Helena F Florindo. "Multivalent Polymeric Nanoparticles for Colorectal Cancer Immunotherapy and Immunomodulation". Paper presented in 9th iMed.ULisboa Postgraduate Students Meeting & 2nd i3DU Meeting, 2017.
  25. Sainz, Vanessa; Peres, Carina; Moura, Liane I F; Ana I. Matos; Viana, Ana S. or Viana, Ana; Lopes, João; Gaspar, Maria Manuela; et al. "Hybrid Lipid-Polymeric Nanoparticles for the Treatment of Melanoma by Strengthening the Host Immune Response". Paper presented in 9th iMed.ULisboa Postgraduate Students Meeting & 2nd i3DU Meeting, 2017.
  26. Peres, Carina; Moura, Liane I F; Ana I. Matos; Sainz, Vanessa; Viana, Ana S. or Viana, Ana; Gaspar, Rogério; Graca, Luis; Préat, Véronique; Helena F Florindo. "Polymeric nanoparticles as breast cancer vaccines and immunomodulators". Paper presented in GRC Cancer Nanotechnology - Multimodal Nano-Therapies Against Cancer, 2017.
  27. Ana I. Matos; Peres, Carina; Moreiras, Hugo; Viana, Ana S. or Viana, Ana; Graca, Luis; Barral, Duarte C.; Gaspar, Rogério; Conde, J.P.; Helena F Florindo. "Multivalent polymeric based biodegradable nanoparticles for colorectal cancer immunotherapy and immunomodulation". Paper presented in GRC Cancer Nanotechnology - Multimodal Nano-Therapies Against Cancer, 2017.
  28. Conniot, João; Scomparin, Anna; Yeini, Eilam; Zupancic, Eva; Peres, Carina; Jung, Steffen; Helena F Florindo; Satchi-Fainaro, Ronit. "Dendritic cell-targeted nanoparticle cancer vaccine enhances immune checkpoint therapy for melanoma". Paper presented in GRC Cancer Nanotechnology - Multimodal Nano-Therapies Against Cancer, 2017.
  29. Moura, Liane I F; Duro-Castano, A; Peres, Carina; Gallon, Elena; Sainz, Vanessa; Ana I. Matos; Gaspar, Rogério; Vicent, María J.; Helena F Florindo. "A novel multifunctional star-shaped polypeptide-based platform as an anti-cancer immunotherapeutic approach". Paper presented in GRC Cancer Nanotechnology - Multimodal Nano-Therapies Against Cancer, 2017.
  30. Helena F Florindo; Zupancic, Eva; Peres, Carina; Sainz, Vanessa; Ana I. Matos; Moura, Liane I F; Curato, Caterina; et al. "Multicomponent Nanoscale Systems for Immune Modulation Against Solid Tumors.". Paper presented in Frontiers in Cancer Immunotherapy, 2017.
  31. Peres, Carina; Sainz, Vanessa; Ana I. Matos; Viana, Ana S. or Viana, Ana; Moura, Liane I F; Graca, Luis; Préat, Véronique; Helena F Florindo. "Multicomponent aliphatic polyester-based nanoparticles for antigen delivery and immune modulation against cancer disease". Paper presented in NanoBio&Med2016, 2016.
  32. Peres, Carina; Viana, Ana S. or Viana, Ana; Graca, Luis; Préat, Véronique; Helena F Florindo. "Polymeric Nanoparticle-Based Vaccine to Target Dendritic Cells and The Tumor Microenvironment". Paper presented in 8th iMed.ULisboa Postgraduate Students Meeting and 1st i3DU Meeting, 2016.
  33. Peres, Carina; Viana, Ana S. or Viana, Ana; Graca, Luis; Préat, Véronique; Helena F Florindo. "Nanoparticle-based cancer vaccine to target dendritic cells and the tumor microenvironment". Paper presented in Encontro Ciência’16, 2016.
  34. Peres, Carina; Ana I. Matos; Catarina Cunha-Santos, A; Viana, Ana S. or Viana, Ana; Wagner, Angela M.; Vela Ramirez, Julia E.; Goncalves, Joao; et al. "Polymeric nanoparticle-based vaccine to target dendritic cells and the tumor microenvironment". Paper presented in UT Austin - Portugal Program Annual Conference, 2016.
  35. Peres, Carina; Ana I. Matos; Viana, Ana S. or Viana, Ana; Graca, Luis; Préat, Véronique; Helena F Florindo. "Polymeric nanoparticle-based vaccine to target dendritic cells and the tumor microenvironment". Paper presented in 14th CIMT Annual Meeting – Mechanisms of efficacy in cancer immunotherapy, 2016.
  36. Peres, Carina; Ana I. Matos; Viana, Ana S. or Viana, Ana; Graca, Luis; Préat, Véronique; Helena F Florindo. "Polymeric nanoparticle-based vaccine to deliver tumor-associated antigens and for immunomodulation". Paper presented in 2nd ASPIC International Congress, 2016.
  37. Peres, Carina; Ana I. Matos; Viana, Ana S. or Viana, Ana; Graca, Luis; Préat, Véronique; Helena F Florindo. "Polymeric nanoparticle-based vaccine: targeting dendritic cells and the tumor microenvironment". Paper presented in XI Spanish-Portuguese Conference on Controlled Drug Delivery "Revolutionary Approaches in Nanomedicine Development”, 2016.
  38. Peres, Carina; Graca, Luis; Préat, Véronique; Helena F Florindo. "Polymeric nanoplatform to deliver tumor-associated antigens and for immunomodulation". Paper presented in 7th iMed.ULisboa Postgraduate Students Meeting, Faculty of Pharmacy of the University of Lisbon, 2015.
  39. Ana I. Matos; Peres, Carina; Ventura, Ana Ester; Viana, Ana S. or Viana, Ana; Borrego, Pedro; Gois, Pedro; Silva, Liana C; Taveira, Nuno; Helena F Florindo. "Development of PLGA-based nanocarriers for Human Immunodeficiency Virus Type 1 vaccine delivery.". Paper presented in Molecular and Supramolecular Carriers for Imaging and Therapy Conference, FP7-PEOPLE-2012-ITN - Marie-Curie Action: "Initial Training Networks", 2015.
  40. Peres, Carina; Gaspar, Rogério; Graca, Luis; Préat, Véronique; Helena F Florindo. "Polymeric nanoparticle-based cancer vaccine to deliver tumor associated antigens and for immunomodulation". Paper presented in GRC Cancer Nanotechnology – Nanomedicines from Laboratory to Clinical Reality, 2015.
  41. Peres, Carina; Silva, Joana M.; Graca, Luis; Gaspar, Rogério; Préat, Véronique; Helena F Florindo. "Multifunctional aliphatic polyester-based biodegradable nanoparticles for vaccine delivery and immunomodulation". Paper presented in Cancer Nanotechnology – Nanomedicines from Laboratory to Clinical Reality, 2015.
  42. Peres, Carina; Graca, Luis; Préat, Véronique; Helena F Florindo. "Nanoparticle-based cancer vaccine to deliver tumor associated antigens and for immunomodulation". Paper presented in 1st ASPIC International Congress, 2014.
  43. Silva, Joana M.; Zupancic, Eva; Peres, Carina; Sainz, Vanessa; Videira, Mafalda; Graca, Luis; Moreira, João Nuno; Préat, Véronique; Helena F Florindo. "Development of multifunctional aliphatic polyester-based biodegradable nanoparticles for vaccine delivery and immunotherapy". Paper presented in Showcasing Portuguese Pharma Science: Advances in Discovery, Development and Manufacturing, 2014.
  44. Peres, Carina; Graca, Luis; Préat, Véronique; Helena F Florindo. "Intracellularly-targeted nanoplatform to target dendritic cells and for immunomodulation". Paper presented in 9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 2014.
  45. Marques, Ricardo; Vaz, CV; Peres, Carina; Gomes, Inês; SANTOS, Cecilia R A; Maia, Cláudio J. B.; Socorro, Sílvia. "Effect of androgens on the expression of Ca2+-binding protein, regucalcin, and Ca2+-channels in MCF-7 cells". Paper presented in 22nd Congress of European Association for Cancer Research - from Basic Research to Personalized Cancer Treatment, 2012.
  46. Maia, Cláudio J. B.; Vaz, CV; Peres, Carina; SANTOS, Cecilia R A; Socorro, Sílvia. "Regucalcin, a calcium-binding protein, is a new target gene in human prostate cancer?". Paper presented in The 16th International Charles Heidelberger Symposium on Cancer Research, 2010.
Journal article
  1. Matos, Ana I.; Peres, Carina; Carreira, Barbara; Moura, Liane I. F.; Acúrcio, Rita C.; Vogel, Theresa; Wegener, Erik; et al. "Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors". Advanced Science (2023): http://dx.doi.org/10.1002/advs.202300299.
    10.1002/advs.202300299
  2. Pires, David; Mandal, Manoj; Matos, Ana I.; Peres, Carina; Catalão, Maria João; Azevedo-Pereira, José Miguel; Satchi-Fainaro, Ronit; Florindo, Helena F.; Anes, Elsa. "Development of Chitosan Particles Loaded with siRNA for Cystatin C to Control Intracellular Drug-Resistant Mycobacterium tuberculosis". Antibiotics 12 4 (2023): 729. http://dx.doi.org/10.3390/antibiotics12040729.
    10.3390/antibiotics12040729
  3. Carreira, Barbara; Acúrcio, Rita A.; Pozzi, Sabina; Kleiner, Ron; Moura, Liane I.; Matos, Ana I.; vaskovich, Daniela; et al. "Abstract 835: Translational nanotechnology-based cancer vaccine to re-educate host immune response against metastatic cancers". Cancer Research 83 7_Suppleme (2023): 835-835. http://dx.doi.org/10.1158/1538-7445.am2023-835.
    10.1158/1538-7445.am2023-835
  4. Peres, Carina; Ana I. Matos; Moura, Liane I F; Acúrcio, Rita C; Carreira, Bárbara; Pozzi, Sabina; Vaskovich-Koubi, Daniella; et al. "Preclinical models and technologies to advance nanovaccine development". Advanced Drug Delivery Reviews (2021):
    Published • 10.1016/j.addr.2021.03.001
  5. Carreira, Bárbara; Acúrcio, Rita C; Ana I. Matos; Peres, Carina; Pozzi, Sabina; Vaskovich-Koubi, Daniella; Kleiner, Ron; et al. "Nanomedicines as Multifunctional Modulators of Melanoma Immune Microenvironment". Advanced Therapeutics (2020): 2000147. http://dx.doi.org/10.1002/adtp.202000147.
    Published • 10.1002/adtp.202000147
  6. Peres, Carina; Tanaka, Yuetsu; Martin, Fabiola; Fox, James. "Flow cytometric methodology for the detection of de novo human T-cell leukemia virus -1 infection in vitro: A tool to study novel infection inhibitors". Journal of Virological Methods 274 (2019): 113728. http://dx.doi.org/10.1016/j.jviromet.2019.113728.
    Published • 10.1016/j.jviromet.2019.113728
  7. Conniot, João; Scomparin, Anna; Peres, Carina; Yeini, Eilam; Pozzi, Sabina; Ana I. Matos; Kleiner, Ron; et al. "Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators". Nature Nanotechnology 14 9 (2019): 891-901. http://dx.doi.org/10.1038/s41565-019-0512-0.
    Published • 10.1038/s41565-019-0512-0
  8. Ana I. Matos; Carreira, Bárbara; Peres, Carina; Moura, Liane I F; Conniot, João; Thibaut Fourniols; Anna Scomparin; et al. "Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer". Journal of Controlled Release 307 (2019): 108-138. https://doi.org/10.1016/j.jconrel.2019.06.017.
    10.1016/j.jconrel.2019.06.017
  9. Moura, Liane I F; Alessio Malfanti; Peres, Carina; Ana I. Matos; Elise Guegain; Vanessa Sainz; Mire Zloh; María J. Vicent; Helena F Florindo. "Functionalized branched polymers: promising immunomodulatory tools for the treatment of cancer and immune disorders". Materials Horizons 6 10 (2019): 1956-1973. https://doi.org/10.1039/C9MH00628A.
    Published • 10.1039/C9MH00628A
  10. Sainz, Vanessa; Moura, Liane I F; Peres, Carina; Ana I. Matos; Viana, Ana S. or Viana, Ana; Wagner, Angela M.; Vela Ramirez, Julia E.; et al. "a-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma". Acta Biomaterialia 76 (2018): 193-207. http://dx.doi.org/10.1016/j.actbio.2018.06.029.
    10.1016/j.actbio.2018.06.029
  11. Silva, Ana Luísa; Peres, Carina; Conniot, João; Ana I. Matos; Moura, Liane I F; Carreira, Bárbara; Sainz, Vanessa; et al. "Nanoparticle impact on innate immune cell pattern-recognition receptors and inflammasomes activation". Seminars in Immunology 34 (2017): 3-24. http://dx.doi.org/10.1016/j.smim.2017.09.003.
    10.1016/j.smim.2017.09.003
  12. Peres, Carina; Ana I. Matos; Conniot, João; Sainz, Vanessa; Zupancic, Eva; Silva, Joana M.; Graca, Luis; et al. "Poly(lactic acid)-based particulate systems are promising tools for immune modulation". Acta Biomaterialia 48 (2017): 41-57. http://dx.doi.org/10.1016/j.actbio.2016.11.012.
    10.1016/j.actbio.2016.11.012
  13. Zupancic, Eva; Peres, Carina; Ana I. Matos; Lopes, João; Moreira, João Nuno; Gaspar, Rogerio S; Helena F Florindo. "Translational Peptide-associated Nanosystems: Promising Role as Cancer Vaccines". Current Topics in Medicinal Chemistry 16 3 (2016): 291-313. http://dx.doi.org/10.2174/1568026615666150701115508.
    10.2174/1568026615666150701115508
  14. Sainz, Vanessa; Peres, Carina; Ciman, T.; Rodrigues, Catarina; Viana, Ana S. or Viana, Ana; Afonso, C. A. M.; Barata, T.; et al. "Optimization of protein loaded PLGA nanoparticle manufacturing parameters following a quality-by-design approach". RSC Advances 6 106 (2016): 104502-104512. http://dx.doi.org/10.1039/c6ra19092h.
    10.1039/C6RA19092H
  15. Sainz, Vanessa; Conniot, João; Ana I. Matos; Peres, Carina; Zupanoio, Eva; Moura, Liane I F; Silva, Liana C; Helena Florindo; Gaspar, Rogerio S. "Regulatory aspects on nanomedicines". Biochemical and Biophysical Research Communications 468 3 (2015): 504-510. http://dx.doi.org/10.1016/j.bbrc.2015.08.023.
    Published • 10.1016/j.bbrc.2015.08.023
  16. Ricardo J Marques; Peres, Carina; Vaz, CV; Gomes, Inês M.; Figueira, Marília I.; Cairrao, Elisa; Ignacio Verde; Maia, Cláudio J. B.; Socorro, Sílvia. "5a-Dihydrotestosterone regulates the expression of L-type calcium channels and calcium-binding protein regucalcin in human breast cancer cells with suppression of cell growth". Medical Oncology 32 9 (2015): http://dx.doi.org/10.1007/s12032-015-0676-x.
    Published • 10.1007/s12032-015-0676-x
Preprint
  1. Kumar, Saumya; Basto, Afonso P.; Ribeiro, Filipa; Almeida, Silvia C. P.; Campos, Patricia; Peres, Carina; Al-Khalidi, Sarwah; et al. "Specialized Tfh cell subsets driving type-1 and type-2 humoral responses in lymphoid tissue". 2022. http://dx.doi.org/10.1101/2022.07.28.501817.
    10.1101/2022.07.28.501817
Thesis / Dissertation
  1. Peres, Carina. "Intracellularly-targeted nanoplatform to target dendritic cells and for immunomodulation". PhD, Universidade de Lisboa Instituto de Investigação do Medicamento, 2020.
  2. Peres, Carina. "Androgens in breast cancer cells physiology: a connection with calcium homeostasis?". Master, Universidade da Beira Interior Centro de Investigação em Ciências da Saúde, 2012.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2023/05/31 Intranasal Segesterone Acetate Nanoemulsion Development – safety evaluation EUFEPS Annual Meeting 2023
EUFEPS (Lisbon, Portugal)
2023/03/20 Nose-to-brain delivery. PhD and Postgraduate Advanced Course – Advanced Drug Delivery
Faculty of Pharmacy, Universidade de Lisboa (Lisbon, Portugal)
2023/03/20 Development of Micro and Nanoemulsions for Intranasal Delivery of the neuroprotectant Nestorone to the brain 4th European Conference on Pharmaceutics
(Marseille, France)
2023/02/14 Development of safe micro and nanoemulsions for nose-to-brain delivery of the neuroprotectant Nestorone HSR Congress 2023
CICS - Centro de Investigação em Ciências da Saúde (Covilhã, Portugal)
2023/02/06 Desenvolvimento de uma nanovacina para o tratamento do cancro de mama CICS-UBI Fora de Portas – O Cancro Trocado por Miúdos
CICS - Centro de Investigação em Ciências da Saúde (Covilhã, Portugal)
2021/01/21 Multivalent branched polypeptide-based nanovaccine as promising immunotherapeutic strategy for melanoma. 3rd SPLC-CRS Young Scientists Virtual Meeting
SPLC-CRS
2020/09/23 Nanotechnological approaches for immune modulation against solid cancers. NanoPT 2020
2020/06/29 Nanovaccines as modulators of germinal center responses against cancer CRS Virtual Meeting 2020
CRS
2019/10/09 Multifunctional nanovaccine synergizes with immune checkpoint therapy against triple negative breast cancer Immunology Club Seminar
Instituto de Medicina Molecular João Lobo Antunes (Lisboa, Portugal)
2019/09/12 Multi-targeting nano-based platform as an effective immunotherapy against solid tumors Nanotechnology in Cancer: Engineering for Oncology
(Cambridge, United Kingdom)
2019/07/21 Dendritic Cell-targeted Nano-vaccines Synergize With Myeloid-Derived Suppressor Cells Inhibitor And Immune Checkpoints Modulators For Melanoma Therapy Controlled Release Society Annual Meeting & Exposition
CRS (Barcelona, Spain)
2019/06/23 Nano-Vaccine Delivery Overcomes Resistance to Immune Checkpoint Therapy GRC Cancer Nanotechnology - Bridging the Translational Gap in Cancer Nanotechnology
Gordon Research Conferences (Mount Snow, West Dover (VT), United States)
2018/11/20 Polymeric nano-vaccines improved immune checkpoint anti-tumor efficacy against breast cancer NanoBio&Med2018
(Barcelona, Spain)
2018/07/22 Dendritic Cell-targeted Nano-vaccines Synergize With Immune Checkpoint Modulators For Melanoma Treatment Controlled Release Society Annual Meeting and Exposition
Controlled Release Society (New York, United States)
2018/05/28 A Novel Multifunctional Polypeptide-Based Nanosystem As An Anti-Cancer Immunotherapeutic Approach For Melanoma 12th International Symposium on Polymer Therapeutics: From Laboratory to Clinical Practice
(Valencia, Spain)
2018/05/28 A Novel Multifunctional Polypeptide-Based Nanosystem As An Anti-Cancer Immunotherapeutic Approach For Melanoma. 12th International Symposium on Polymer Therapeutics: From Laboratory to Clinical Practice
(Valencia, Spain)
2018/01/14 Combination of Dendritic Cell-targeted Nano-vaccines with Immune Checkpoint Therapy for Melanoma XII Spanish-Portuguese Conference on Controlled Drug Delivery
Spanish-Portuguese Conference on Controlled Drug Delivery (Coimbra, Portugal)
2017/11/22 Combination of Dendritic Cell-targeted Nano-vaccines with Immune Checkpoint Therapy for Melanoma NanoBio&Med2017
(Barcelona, Spain)
2017/07/13 Dendritic Cell-targeted Nano-vaccines Synergize with Immune Checkpoint Therapy for Melanoma 9th iMed.ULisboa and 2nd I3DU Postgraduate Students Meeting
(Lisbon, Portugal)
2017/04/23 A novel nanoplatform as metastatic melanoma cancer vaccine 1st SPLC-CRS Young Scientist Meeting
Spanish-Portuguese Conference on Controlled Drug Delivery (Santiago de Compostela, Spain)
2016/09/03 Nanoparticle-based cancer vaccine to target dendritic cells and the tumor microenvironment 41st Federation of European Biochemical Societies (FEBS) congress
Federation of European Biochemical Societies (Ephesus/Kusadasi, Turkey)
2016/08/31 Nanoparticle-based cancer vaccine to target dendritic cells and the tumor microenvironment 16th FEBS Young Scientists’ Forum
Federation of European Biochemical Societies (Ephesus/Kusadasi, Turkey)
2016/01/21 Melanoma cancer vaccine based on multifunctional nanoparticles for antigen delivery and immunomodulation. XI Spanish-Portuguese Conference on Controlled Drug Delivery "Revolutionary Approaches in Nanomedicine Development”
Spanish-Portuguese Conference on Controlled Drug Delivery (Granada, Spain)
2016/01/21 Development of polymeric vaccine delivery nanosystems for HIV/AIDS control through dendritic cell modulation XI Spanish-Portuguese Conference on Controlled Drug Delivery "Revolutionary Approaches in Nanomedicine Development”
Spanish-Portuguese Conference on Controlled Drug Delivery (Granada, Spain)
2015/11/26 Androgens as calcium-modulators in human breast cancer cells: effect of the 5a-dihydrotestosterone in MCF-7 cells I Congress in Health Sciences Research: Towards Innovation and Entrepreneurship Trends in Endocrinology and Neurosciences
(Covilhã, Portugal)
2015/07/13 Multicomponent nanoparticles for vaccine delivery and immunomodulation Molecular and Supramolecular Carriers for Imaging and Therapy Conference, FP7-PEOPLE-2012-ITN - Marie-Curie Action: "Initial Training Networks"
FP7-PEOPLE-2012-ITN - Marie-Curie Action (Lisbon, Portugal)
2014/10/10 Multivalent nanoparticle-based cancer vaccine to deliver tumor-associated antigens and for immunomodulation Workshop Nano2014
(Lisbon, Portugal)
2014/07/02 PLA-based nanoparticles as a cancer vaccine to deliver tumor-associated antigens and for immunomodulation 6th iMed.ULisboa Postgraduate Students Meeting
(Lisbon, Portugal)
2013/12/18 Intracellularly-targeted nanoplatform to target dendritic cells and for immunomodulation Nanomedicines classes of the 5th year of the Integrated Master in Pharmaceutical Sciences
Universidade de Lisboa, Faculty of Pharmacy (Lisbon, Portugal)
2012/07/03 Androgens in breast cancer cells physiology - a connection with calcium homeostasis? VI Symposium of the Health Sciences Research Centre
(Covilhã, Portugal)
2012/07/03 Regucalcin regulation by extracellular calcium in prostate cells. VI Symposium of the Health Sciences Research Centre
(Covilhã, Portugal)

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2021/09/01 - 2021/12/31 Modulation of melanoma tumor microenvironment
Co-supervisor
 Ciências Farmacêuticas (Scientific initiation)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2021/03/01 - 2021/09/30 Dendritic cell regulation by a novel mannosylated nanovaccine
Co-supervisor
 Ciências Farmacêuticas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2021/03/01 - 2021/06/30 Development of nanoparticle-based immunotherapy using chitosan as an immunomodulator
Co-supervisor
 Biologia Celular e Molecular (Degree)
Universidade NOVA de Lisboa Faculdade de Ciências e Tecnologia, Portugal
2020/09 - 2020/12 Production of a novel mannosylated nanovaccine
Co-supervisor
 Ciências Farmacêuticas (Scientific initiation)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2017/09 - 2018/02 Polymeric nanoparticle-based vaccine: the impact of surfactants and mannose functionalization on in vitro uptake by APC
Co-supervisor
 Ciências Farmacêuticas (Scientific initiation)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2014/09 - 2015/02 Vaccination with PLGA nanoparticles: formulation and quantification of the residual surfactant
Co-supervisor
 Mestrado integrado em Ciências Farmacêuticas (Scientific initiation)
Universidade de Lisboa Faculdade de Farmácia, Portugal

Event organisation

Event name
Type of event (Role) 		Institution / Organization
2014/09/01 - 2014/09/28 European Researcher's Night, National Museum of Natural History and Science, Lisbon, Portugal (2014/09/27 - 2014/09/27)
2014/07/01 - 2014/07/05 6th iMed.ULisboa Postgraduate Students Meeting, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal (2014/07/03)
Meeting (Member of the Organising Committee)
 Universidade de Lisboa Faculdade de Farmácia, Portugal
2014/03/25 - 2014/04/04 9th World Meeting on Pharmaceutics, Biopharmaceutics, and Pharmaceutical Technology, Centro de Congressos de Lisboa, Lisbon, Portugal (2014/03/31 - 2014/04/03)
Congress (Co-organisor)
2013/09/01 - 2013/09/28 European Researcher's Night, National Museum of Natural History and Science, Lisbon, Portugal (2013/09/27 - 2013/09/27)
2013/07/01 - 2013/07/19 5th iMed.UL Postgraduate Students Meeting, Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal (2013/07/18)
Meeting (Member of the Organising Committee)
 Universidade de Lisboa Faculdade de Farmácia, Portugal
2009/11/01 - 2009/11/30 4th National Meeting of Biochemistry Students (ENEBIOQ), Universidade da Beira Interior, Covilhã, Portugal (2009/11/26 - 2009/11/29)
Meeting (Co-organisor)
 Universidade da Beira Interior, Portugal

Jury of academic degree

Topic
Role 		Candidate name (Type of degree)
Institution / Organization
2021/02/23 Nanoplatform to modulate dendritic cells and tumor microenvironment against triple negative breast cancer
(Thesis) Arguer
 Mafalda Carvalho Verdial (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal

Association member

Society Organization name Role
2016/02 - Current Spanish-Portuguese Local Chapter of the Controlled Release Society (SPLC-CRS)
2015/06 - Current Association for Cancer Immunotherapy (CIMT)
2015/03 - Current Portuguese Association for Cancer Research (ASPIC)
2015/03 - Current European Association for Cancer Research (EACR)
2013/04 - 2017/03 Portuguese Biochemical Society (SPB)

Committee member

Activity description
Role 		Institution / Organization
2013/01 - 2014/12 iMed.ULisboa postgraduate Students Commission (ipSC) Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Journal scientific committee

Journal title (ISSN) Publisher
2021/01 - Current Drug Delivery and Translational Research Springer
Distinctions

Award

2022 Bursary to attend the 2022 IUBMB-FEBS-PABMB YSF and FEBS Congresses
Federation of European Biochemical Societies, United Kingdom
2018 Travel Award to attend the 16th CIMT Annual Meeting¿- Pushing Frontiers in Cancer Immunotherapy
2018 Best Poster Award at the 10th iMed.ULisboa Postgraduate Students Meeting & 3rd i3DU Meeting
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal
2017 Bursary to attend the training school entitled "Drug Discovery and Development" at Novartis (Basel, Switzerland)
2016 Travel Award to attend the 14th CIMT Annual Meeting - Mechanisms of Efficacy in Cancer Immunotherapy
2016 Bursary to attend the 16th FEBS Young Scientists Forum/ 41st Federation of European Biochemical Societies (FEBS) congress, Kusadasi, Turkey
2015 Young Scientist Award for the best oral presentation at the Molecular and Supramolecular Carriers for Imaging and Therapy Conference
2015 Bursary to attend the training school entitled "Creating and Phenotyping Mouse models of Disease and Ageing", at MRC Harwell Institute (United Kingdom)
2012 Short Oral Communication Award at the VII Annual CICS Symposium
Universidade da Beira Interior, Portugal
2012 PhD fellowship (SFRH/BD/87591/2012)
Fundação para a Ciência e a Tecnologia, Portugal
2010 Merit Scholarship
Universidade da Beira Interior, Portugal

Ministério da Educação, Portugal